NPA leader weighs in on what elections mean for industry
WASHINGTON This year’s elections may prove to be a boon to the business of dietary supplements and other natural alternatives, according to John Gay, Natural Products Association executive director and CEO. “This was the most remarkable election in my 25 years in Washington,” he said, “and the effects will be felt almost immediately.”
For example, Rep. Henry Waxman, D-Calif., who must now step down as chairman of the House Energy and Commerce Committee, is seen as a potential positive for the industry, Gay said.
The Energy and Commerce Committee oversees the Food and Drug Administration.
With additional authority unlikely to be granted by the new Congress, NPA expects federal regulators to test the limits of their existing powers. “We support their actions aimed at getting the bad actors out of the market,” Gay said, “but it is a problem if they target the legitimate industry, especially if they go beyond the current law to do so.”
In the Senate, industry champions, such as Sens. Orrin Hatch, R-Utah, and Tom Harkin, D-Iowa, remain well-positioned “to continue their work,” Gay said. One wild card is Sen. John McCain, R-Ariz. “Will he introduce another version of his Dietary Supplement Safety Act, or will he continue to work with Sen. Hatch? That is a key question,” Gay said.
DiabetesSisters kicks off campaign aimed at diabetic women
RALEIGH, N.C. A nonprofit that seeks to improve the health and quality of life of women with — and those at risk of developing — diabetes has kicked off a national campaign.
DiabetesSisters said that its OrangeWill campaign represents the will and determination required for women to manage their diabetes on top of their many other responsibilities.
"For far too long women with diabetes have been overlooked and divided into separate groups based on the type of diabetes they have. Now is the time for us to come together and make our voice heard," said Brandy Barnes, founder and CEO of DiabetesSisters.
More information can be found at Orangewill.org.
Study finds ProbioKid reduces infections in children during winter months
MONTREAL A study presented last month before the European Respiratory Society Annual Congress determined that the branded probiotic ProbioKid reduced infectious events in children by 25% during the winter period, as compared with a placebo. The study was conducted during the winter of 2006-2007 and involved 135 healthy, school-aged children who had suffered from at least three episodes of ear-nose-throat, bronchopulmonary or gastric disorder during the course of the previous winter.
Half of the children in the probiotic group did not develop any ENT, bronchopulmonary or gastric disorder during the winter, versus 32.9% of children in the placebo group.
ProbioKid, distributed by Institut Rosell-Lallemand, contains a combination of three probiotic strains and a prebiotic.